Are Prices for Veterinary Services Really Rising? A Recent VPI-Purdue Study and its Significance to the Veterinary Diagnostics Market

Are Prices for Veterinary Services Really Rising? A Recent VPI-Purdue Study and its Significance to the Veterinary Diagnostics Market

A recent insurer-sponsored study sought to define real pricing trends for services in the U.S. veterinarian industry. It found surprisingly that during the recession and afterwards (2009-2014) prices overall for canine veterinary services actually fell according to the generated index. An overall drop in veterinary service prices seemed counterintuitive to industry observations and even the government consumer price index for veterinary services. Kalorama Information outlines this prevailing not...


Superbug Raises Device and Facility HAI Concerns

Superbug Raises Device and Facility HAI Concerns

In terms of prevention for healthcare associated infections (HAI), it’s notable that the market for facillity sterilization is just over 3.1 billion dollars but the market to treat them is much larger at 10 billion. Ideally, the market for treatment should shrink as prevention grows. This may happen, and prevention may become more of a focus now, with the recent superbug concern at UCLA Medical Center. 180 patients may have been exposed to a CRE (carbapenem-resistant enterobacteriaceae) threat, ...


Mass Spec Imaging Develops Tissue Samples as Resource for Proteomic Biomarker Discovery

This blog post covers market trends in proteomics research - a field recently profiled by Kalorama Information with Proteomics Research Markets: Instruments (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other) Market Share and Trends. The report offers unique insight into a mass spectrometry- and analytical separation-centric life sciences market, including market shares by geography, instrument type, and vendor.

Mass spectrometr...


Kalorama on Fox Business News: The Business of Vaccines

Kalorama on Fox Business News: The Business of Vaccines

How big is the business of vaccines? Yesterday, Fox Business News featured information from Kalorama’s global vaccine report. They reported our estimate of the market at 25.5 billion in 2014. Most of that is childhood vaccines, though influenza is also a large category. But as Fox Business News pointed out, it’s not as profitable as the rest of the pharmaceutical market. Vaccines are expensive to make, facilities are expensive and outsourcers can often be at capacity in peak seasons. Thus there ...

  • by bcarlson@marketresearch.com
  • February 9 2015


Siemens’s Layoffs: IVD Market Impact

Where will the cuts go? That’s the question being asked as Siemens announced that they will eliminate more than 2% of its workforce in a streamlining move meant to save $1.13 bil (1 bil euros). The company plans to layoff 7,800 employees. Kalorama covers Siemens, and other top tier IVD companies, in its report, The Worldwide Market for In Vitro Diagnostics, 9th Edition. http://www.kaloramainformation.com/Worldwide-Vitro-Diagnostic-8326563/

Siemens has not commented on where layoffs would be bu...


Alzheimer’s Disease Assays Target Clinical Trial Markets First

Alzheimer’s Disease Assays Target Clinical Trial Markets First

Outside of the $50+ billion clinical in vitro diagnostics (IVD) market , analytical instruments and lab diagnostics find major applications in the discovery of clinically significant biomarkers, therapeutics development, and other life sciences research activities. Entire classes of assays are originally developed to validate biomarkers as surrogate endpoints for disease, or as mechanism targets for drug development. The potential of pre-clinical assay markets is not lost to Amarantus BioScience...